抗生素丰富提取物在性结肠炎患者的有效性和安全性:一项随机对照试验
Luc Biedermann1, Michael Doulberis1,2,3, Philipp Schreiner1
1Department of Gastroenterology and Hepatology, University Hospital Zurich, University of Zurich, 8091 Zurich, Switzerland.
来自白的富含安东素提取物 (ACRE) 显示,性结肠炎 (UC) 患者的中calprotectin显著降低. 然而,由于具有较高的安慰剂效应,ACRE在临床反应方面没有表现出优于安慰剂的优势.
科学领域:
- 胃肠病学 胃肠病学
- 临床营养学 临床营养学
- 药理学 药理学是指药理学的学科.
背景情况:
- 蓝以其在性结肠炎 (UC) 中的治疗作用而闻名.
- 在UC治疗中,研究了白的关键成分 - - 富含安东素的提取物 (ACRE).
- 之前的研究结果表明,白在改善UC患者的临床,内镜和生化标志物方面的疗效.
研究的目的:
- 评估在中度至重度性结肠炎 (UC) 患者中富含圣素提取物 (ACRE) 的疗效.
- 进行多中心,随机,安慰剂控制,双盲临床试验.
- 评估临床反应,便calprotectin水平和内镜反应作为初级和二级终点.
主要方法:
- 采用了一个多中心,随机,安慰剂控制,双盲研究设计.
- 患有中度至重度活性UC的患者随机分配给接受ACRE或安慰剂.
- 该研究评估了第8周的临床反应,便calprotectin和内镜反应.
主要成果:
- 一半的ACRE组 (9/18) 和安慰剂组的3/8显示出临床反应 (p=0.278).
- 便中calprotectin水平在ACRE组显著下降 (p=0.035),但在安慰剂组没有.
- 严重的不良事件是罕见的,并且在ACRE手臂中注意到梅奥得分的改善.
结论:
- 富含安托素的提取物 (ACRE) 在诱导UC患者临床反应方面没有显著优于安慰剂.
- 观察到高的安慰剂反应率,这可能会影响研究的统计能力.
- 便calprotectin的显著下降表明ACRE在减少UC肠道炎症方面的潜在有效性.
更多相关视频
08:58Analyzing Beneficial Effects of Nutritional Supplements on Intestinal Epithelial Barrier Functions During Experimental Colitis
Published on: January 5, 2017
12:00Extraction and Purification of Polyphenols from Freeze-dried Berry Powder for the Treatment of Vascular Smooth Muscle Cells In Vitro
Published on: July 5, 2017
相关概念视频
Drugs for Treatment of Ulcerative Colitis in IBD
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
Peptic Ulcer Disease IV: Management
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
